Ophthalmology Drugs Market Global Briefing 2022: Ukraine-Russia War Impact

Sep 2022| MKB187H| TBRC (Publisher)

Report Highlights

Including: Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)

Global ophthalmology drugs market was worth $50.6 billion in 2021, it was the ninth largest segment within the market accounting for 3.4%. In terms of per capita consumption, the market was $6.6 and in terms of global GDP, the market was 0.05%. Ophthalmology drugs was the ninth largest segment within the market accounting for 3.4% preceded and followed by gastrointestinal drugs and at 4.9% respectively.

Ophthalmology Drugs Market Global Briefing 2022: Ukraine-Russia War Impact provides strategists, marketers and senior management with the critical information they need to assess the global ophthalmology drugs sector.

Reasons to Purchase

  • Fully updated for 2022 with Ukraine-Russia War Impact.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.

Description

Ophthalmology Drugs Market Global Briefing 2022: Ukraine-Russia War Impact from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, trends and strategies for this market.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the ophthalmology drugs market revenues, covering both the historic growth of the market and forecasting the future.
  • Market segmentations break down the key sub sectors which make up the market.
  • The regional breakdowns section gives the size of the market geographically.
  • The trends and strategies section highlights the likely future developments in the ophthalmology drugs market and suggests approaches.

 

 

Scope

Markets Covered: Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)

Geographic scope: Asia Pacific, North America, Western Europe, Eastern Europe, South America, Middle East, Africa

Time series: Five years historic and forecast

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Ophthalmology Drugs Market, Historic Market Size, 2016-2021, $
  • Table 2 : Global Ophthalmology Drugs Market, Forecast Market Size, 2021-2026, $
  • Table 3 : Global Ophthalmology Drugs Market, Split By Segment, 2021, $
  • Table 4 : Global Ophthalmology Drugs Market, Historic And Forecast, Split By Segment, 2016-2026
  • Table 5 : Global Ophthalmology Drugs Market, Split By Region, 2021, $
  • Table 6 : Global Ophthalmology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2016-2026
  • Table 7 : Ophthalmology Drugs Market Data Sources
  • Figure 1 : Global Ophthalmology Drugs Market, Historic Market Size, 2016-2021, $
  • Figure 2 : Global Ophthalmology Drugs Market, Forecast Market Size, 2021-2026, $
  • Figure 3 : Global Ophthalmology Drugs Market, Split By Segment, 2021, $
  • Figure 4 : Global Ophthalmology Drugs Market, Historic And Forecast, Split By Segment, 2016-2026
  • Figure 5 : Global Ophthalmology Drugs Market, Split By Region, 2021, $
  • Figure 6 : Global Ophthalmology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2016-2026

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Ophthalmology Drugs Global Market Competitor Briefing 2021

  • Date - Dec 2021
  • Code - MKB187G

Including: Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); Antiglaucoma Drugs; Dry Eye Medication
Covering: Regeneron Pharmaceuticals, Inc.; Novartis AG; AbbVie; Santen Pharmaceutical Co.; F. Hoffmann-La Roche Ltd.

Regeneron Pharmaceuticals, Inc. was the largest competitor with 27.83% of the market followed by Novartis AG and AbbVie

Ophthalmology Drugs Global Market Competitor Briefing 2021 provides strategists, marketers and senior management with the critical ...

Ophthalmology Drugs Investment Competitor Outlook 2020: Covid 19 Impact and Recovery

  • Date - Nov 2020
  • Code - MKB187F

Including: Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); Antiglaucoma Drugs; Dry Eye Medication

Covering: Regeneron Pharmaceuticals, Inc.; Novartis AG; Allergan Plc.; Santen Pharmaceutical Co.; F. Hoffmann-La Roche Ltd

Regeneron Pharmaceuticals, Inc. was the largest competitor with 23.66% of the market followed by Novartis AG and Allergan Plc.

Ophthalmology Drugs Investment Competitor Outlook 2020: Covid 19 Impact and Recovery provides ...

Ophthalmology Drugs Market Global Briefing 2020: Covid 19 Impact and Recovery

  • Date - Apr 2020
  • Code - MKB187E

Including: Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)

Ophthalmology Drugs Market Competitor Briefing 2019

  • Date - Nov 2019
  • Code - MKB187D

Including: Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)

Covering: Novartis AG; Bayer AG; Allergan Plc.; Santen Pharmaceutical Co.; F. Hoffmann-La Roche Ltd.

Research Methodology
The report is built on information collected through secondary sources and analysis done by The Business Research
Company (TBRC). The secondary sources include the data published by statistical bodies, government ...

Ophthalmology Drugs Market Global Briefing 2019

  • Date - May 2019
  • Code - MKB187C

Research Methodology

The report is built on information collected through secondary sources and analysis done by The Business Research Company (TBRC). The secondary sources include the data published by statistical bodies, government agencies, market intelligence databases and annual reports. Insights on the current market scenario, historic and forecast market drivers were gathered from industry reports and news articles.

Note on ...

Ophthalmology Drugs Market Global Briefing 2018

  • Date - Jan 2018
  • Code - MKB187B

Including: Ophthalmology Drugs, Dry Eye Medication, Antiglaucoma Drugs

Covering: Novartis AG, F. Hoffmann-La Roche Ltd., Allergan Plc., Valeant Pharmaceuticals Intl Inc., Bayer AG, Santen Pharmaceutical Co., Ltd., Gilead, Otsuka Pharmaceutical Co., Ltd., Shire Plc.

Research Methodology

The Business Research Company’s reports are based on the methodology below.

Data –

Our datasets are created using a wide range of proprietary and ...

Ophthalmology Drugs Market Global Briefing 2017

  • Date - Jul 2017
  • Code - MKB187A

Including: Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs.

Covering: Novartis AG, F. Hoffmann-La Roche Ltd., Allergan Plc., Valeant Pharmaceuticals Intl Inc., Bayer AG, Santen Pharmaceutical Co., Ltd., Gilead, Otsuka Pharmaceutical Co., Ltd., Shire Plc.

Research Methodology

The Business Research Company’s reports are based on the methodology below.

Data 

Our datasets are created using a wide range of proprietary and ...

The Business Research Company
Price: $2500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS